| ¿µ¹® | cranial nerve | ÇÑ±Û | ³ú½Å°æ |
|---|---|---|---|
| ¼³¸í | ´ëºÎºÐÀÇ ½Å°æÀº ô¼ö¸¦ ÅëÇØ¼ ³ª°£´Ù. ±×·¯³ª ¸î¸îÀÇ ½Å°æÀº ³ú¿¡¼ ¹Ù·Î ³ª°£´Ù. ÀÌ·¸°Ô ³ú¿¡¼ ¹Ù·Î ³ª°¡´Â ½Å°æÀ» ³ú½Å°æÀ̶ó°í ÇÑ´Ù. ÀÌ ³ú½Å°æÀº 12°³·Î ¸ðµÎ ´ëĪÀûÀÎ ½ÖÀ¸·Î Á¸ÀçÇÑ´Ù. ÀÌ ³ú½Å°æÀº ÁַΠƯ¼ö°¨°¢(½Ã°¢, û°¢, Èİ¢, ¹Ì°¢)°ú ¾ó±¼ µîÀÇ ÀϺΠ±ÙÀ°À» Áö¹èÇÏ°í ½ÉÀåÀ̳ª ³»ÀåÀÇ Áö¹èµµ ÀϺΠ´ã´çÇϰí ÀÖ´Ù. 12°³ÀÇ ½Å°æÀº °¢°¢ ´ÙÀ½°ú °°Àº À̸§°ú °íÀ¯¹øÈ£¸¦ °¡Áö°í ÀÖ´Ù. -Èİ¢½Å°æ(olfactory nerve)£Èİ¢À» ´ã´çÇÏ´Â ½Å°æ, -½Ã°¢½Å°æ(optic nerve)£½Ã°¢À» ´ã´çÇÏ´Â ½Å°æ. -´«µ¹¸²½Å°æ(oculomotor nerve)£¿îµ¿À» ´ã´çÇÏ´Â ½Å°æ, -µµ¸£·¡½Å°æ(trochlear nerve)£´«ÀÇ ¿îµ¿À» ´ã´çÇÏ´Â ½Å°æ. -»ïÂ÷½Å°æ(trigeminal nerve)£3°³ÀÇ °¡Áö¸¦ °¡Áö´Â ½Å°æÀ¸·Î ¾ó±¼ÀÇ °¨°¢°ú ¾Ã±â¸¦ À§ÇÑ ±ÙÀ°À» ¿òÁ÷ÀÌ´Â ¿ªÇÒÀ» ÇÑ´Ù. -°¡µ¹¸²½Å°æ(abducent nerve)£´«ÀÇ ¿îµ¿À» ´ã´çÇÏ´Â ½Å°æ. -¾ó±¼½Å°æ(facial nerve)£¾ó±¼ ±ÙÀ°ÀÇ ¿îµ¿À» ´ã´çÇÏ´Â ½Å°æ. Áï ¾ó±¼ÀÌ ¿©·¯ °¡Áö Ç¥Á¤À» ³»´Â °ÍÀº ÀÌ ½Å°æÀÇ ÀÛ¿ëÀÌ´Ù. ±×¸®°í ÇôÀÇ ¾ÕºÎºÐÀÇ ¹Ì°¢À» ´ã´çÇÏ´Â ¿ªÇÒµµ ÇÑ´Ù. -¾È¶ã´ÞÆØÀ̽Űæ(vestibulocochlear nerve)£¾È¶ã½Å°æ°ú ´ÞÆØÀ̽ŰæÀÇ 2°¡Áö ½Å°æÀ¸·Î ÀÌ·ç¾îÁø ½Å°æÀ¸·Î ¸ðµÎ ±Í¸¦ Áö¹èÇÏ´Â ½Å°æÀÌ´Ù. ¾È¶ã½Å°æÀº ÆòÇü°¨°¢À» ´ã´çÇÏ´Â °÷ÀÎ ±ÍÀÇ ¾È¶ã¿¡¼ ³ª¿À´Â ½Å°æÀ¸·Î ÆòÇü°¨°¢ÀÇ Á¤º¸¸¦ ³ú¿¡ ÀüÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. ±×¸®°í ´ÞÆØÀ̽ŰæÀº û°¢À» °¨ÁöÇÏ´Â ´ÞÆØÀ̲®ÁúÀÇ ¸ð¾çÀ» °¡Áø ´ÞÆØÀÌ¿¡¼ ±â¿øÇÏ´Â ½Å°æÀ¸·Î û°¢ÀÇ Á¤º¸¸¦ ³ú¿¡ Àü´ÞÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. -ÇôÀενŰæ(glossopharyngeal nerve)£¸» ±×´ë·Î Çô¿Í Àεκο¡ ºÐÆ÷ÇÏ´Â ½Å°æÀ¸·Î ÀÎÈĺÎÀÇ ¿òÁ÷ÀÓ°ú ÇôÀÇ µÞºÎºÐÀÇ ¹Ì°¢À» ´ã´çÇÑ´Ù. -¹ÌÁֽŰæ(vagus nerve)£¸» ±×´ë·Î ¾ÆÁÖ ¿©·¯ °÷¿¡ ºÐÆ÷ÇÏ¿© ºÐÆ÷¿µ¿ªÀÌ ¸ðÈ£ÇÑ ½Å°æÀÌ´Ù(vagus¶õ ¸ðÈ£ÇÑ À̶õ ¶æÀ» °¡Áø´Ù). ´ëºÎºÐÀÇ ³»Àå¿¡ ºÐÆ÷ÇÏ°í ¶Ç ½ÉÀå¿¡ ºÐÆ÷ÇÏ¿© ½ÉÀåÀÇ ¹Úµ¿¼ö¸¦ Á¶Á¤ÇÏ´Â ¿ªÇÒµµ ÇÑ´Ù. -´õºÎ½Å°æ(accessory nerve)£µîÀÇ ±ÙÀ°°ú ¸ñÀÇ ±ÙÀ°ÀÇ ÀϺθ¦ Áö¹èÇÏ´Â ½Å°æ. -Çô¹Ø½Å°æ(hypoglossal nerve)£ÇôÀÇ ¿òÁ÷ÀÓÀ» °üÀåÇÏ´Â ½Å°æ. |
||
| ¿µ¹® | afferent nerve | ÇÑ±Û | µé½Å°æ |
|---|---|---|---|
| ¼³¸í | ¸öÀÇ Áß½ÉÀ¸·Î µé¾î¿À´Â ½Å°æ, Áï °¨°¢½Å°æÀ» ÁöĪÇÏ´Â ¸»ÀÌ´Ù. |
||
| ¿µ¹® | peripheral nerve | ÇÑ±Û | ¸»ÃʽŰæ |
|---|---|---|---|
| ¼³¸í | ÁßÃ߽Űæ°è¸¦ Á¦¿ÜÇÑ ³ª¸ÓÁö ¸ðµç½Å°æÀ» ¸»ÇÔ. ÁßÃ߽Űæ°è´Â ³ú¿Í ô¼ö¸¦ ¸»Çϸç, ±×¿Ü ³ª¸ÓÁö ½Å°æµé·Î½á ½ÇÁ¦ÀûÀ¸·Î °¢ ±â°üÀ̳ª »çÁö ¸»´Ü¿¡ ½Å°æÀÌ ºÐÆ÷Çϸç, ÀÚ±ØÀ» Àü´ÞÇÏ´Â ÀÏÀ» ÇÏ´Â ½Å°æÀ» ¸ðµÎ ÅëÆ²¾î ¸»ÃʽŰæÀ̶ó ÇÑ´Ù. ³ú¿¡¼ ¹Ù·Î ³ª¿Í ºÐÆ÷ÇÏ´Â ³ú½Å°æ°ú ô¼ö¿¡¼ ±â½ÃÇϴ ô¼ö½Å°æµµ ¸ðµÎ ¸»ÃʽŰ濡 ÇØ´çÇÑ´Ù. ¶ÇÇÑ ¸»ÃʽŰ濡´Â °¢Á¾ ÀÚÀ²½Å°æÀ» ´ã´çÇÏ´Â ±³°¨½Å°æ, ºÎ±³°¨½Å°æµµ Æ÷ÇԵȴÙ. |
||
| ¿µ¹® | optic nerve | ÇÑ±Û | ½Ã°¢½Å°æ |
|---|---|---|---|
| ¼³¸í | ½Ã°¢À» ÀÎÁöÇÏ´Â ½Å°æ. ÀÌ ½Å°æÀº ´ÜÁö °¨°¢½Å°æÀ¸·Î¼¸¸ ÀÛ¿ëÇÑ´Ù. µû¶ó¼ ¾î¶² »ç¹°À» µû¶ó ´«À» ¿òÁ÷ÀÏ ¼ö ÀÖ´Â °ÍÀº ÀÌ ½Ã°¢½Å°æ°ú´Â ¹«°üÇÏ´Ù(À̰ÍÀº ´«µ¹¸²½Å°æ(oculomotor nerve)¿¡ ÀÇÇØ °¡´ÉÇÏ´Ù). ¶ÇÇÑ ½Ã°¢½Å°æÀº °íÀ§ÁßÃ߽Űæ°èÀÎ ³ú¿¡¼ Á÷Á¢ ºÐÁöÇϹǷΠ¼Õ»ó½Ã Àç»ýÀº ºÒ°¡´ÉÇϸç, ÀÌ¿¡ ´ëÇÑ Ä¡·á¹ýÀº ¾ø´Ù. |
||
| AChRs | Acetylcholine Receptors |
|---|---|
| RA | radioactive; ragocyte; ragweed antigen; rapidly adapting [receptors]; reactive arthritis; reciprocal... |
| GF | gastric fistula; gastric fluid; germ-free; glass factor; glomerular filtration; gluten-free; grandfa... |
| SGF | sarcoma growth factor; skeletal growth factor |
| PAF | paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl... |
| heparin binding growth factor | <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells. Synonym: heparin binding growth factor. Acronym: FGF (18 Nov 1997) |
|---|---|
| hepatocyte growth factor | <growth factor> Polypeptide mitogen originally shown to cause cell division in hepatocytes. In the liver, the main sources of hepatocyte growth factor are nonparenchymal cells. It is now clear that hepatocyte growth factor is a mitogen for a number of cell types and it is found in many cells outside the liver, including platelets. Hepatocyte growth factor is synthesised as a single chain precursor that is proteolytically cleaved to give a heavy chain (70 kD) and a light chain (30 kD) linked by a single disulphide bond. It contains multiple copies of the kringle domain. However, both the single chain precursor and the two chain forms of hepatocyte growth factor are biologically active and hepatocyte growth factor is generally isolated as a mixture of the two forms. Hepatocyte growth factor also alters cell motility and is now known to be identical to scatter factor. Acronym: HGF (18 Nov 1997) |
| pro-transforming growth factor-alpha processing protease | <enzyme> Converts membrane-bound protgf-alpha to soluble tgf-alpha; mw 84 kD Registry number: EC 3.4.21.- Synonym: protgf-alpha converting enzyme, protgfalpha processing protease (26 Jun 1999) |
| schwannoma derived growth factor | <growth factor> A growth factor containing an EGF like domain, mitogenic for astrocytes, Schwann cells and fibroblasts. (18 Nov 1997) |
| insulin like growth factor | <growth factor> Insulin like growth factors I and II are polypeptides with considerable sequence similarity to insulin. They are capable of eliciting the same biological responses, including mitogenesis in cell culture. On the cell surface, there are two types of insulin like growth factor receptor, one of which closely resembles the insulin receptor (which is also present). Insulin like growth factor I = somatomedin A = somatomedin C Insulin like growth factor II = MSA (Multiplication stimulating activity). Insulin like growth factor 1 is released from the liver in response to growth hormone. Acronym: IGF (18 Nov 1997) |
| insulin-like growth-factor binding protein 1 | One of the six homologous proteins that specifically bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions. The function of this protein is not completely defined. However, several studies demonstrate that it inhibits igf binding to cell surface receptors and thereby inhibits igf-mediated mitogenic and cell metabolic actions. (proc soc exp biol med 1993;204(1):4-29) (12 Dec 1998) |
| insulin-like growth factor-binding protein 2 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin-like growth factor binding protein 3 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin like growth-factor-binding protein 4 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin-like growth-factor-binding-protein 5 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin-like-growth-factor-binding protein 6 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin-like growth-factor-binding proteins | A family of soluble proteins that bind insulin-like growth factors and modulate their biological actions at the cellular level. (int j gynaecol obstet 1992;39(1):3-9) (12 Dec 1998) |
| insulin-like growth factor I | <chemical> A well-characterised basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on somatotropin. It is believed to be mainly active in adults in contrast to insulin-like growth factor II, which is a major foetal growth factor. Chemical name: Insulin-like growth factor I (12 Dec 1998) |
| insulin-like growth factor II | <chemical> A well-characterised neutral peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on somatotropin. It is believed to be a major foetal growth factor in contrast to insulin-like growth factor I, which is a major growth factor in adults. Chemical name: Insulin-like growth factor II (12 Dec 1998) |
| T-cell growth factor | <cytokine> A hormone-like substance released by stimulated T lymphocytes, causes activation and differentiation of other T lymphocytes independently of antigen. A type of interleukin, a chemical messenger, a substance that can improve the body's response to disease. It stimulates the growth of certain disease-fighting blood cells in the immune system. It is secreted by Thl CD4 cells to stimulate CD8 cytotoxic T-1yrnphocytes. Interleukin 2 also increases the proliferation and maturation of the CD4 cells themselves. During HIV infection, Interleukin-2 production gradually declines. Use of interleukin 2 therapy is under study as a way to raise CD4 cell counts and restore immune function. Acronym: IL-2 (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|